In vivo release of endogenous dopamine from rat caudate nucleus by phenylethylamine
- PMID: 6664462
- DOI: 10.1016/0028-3908(83)90203-4
In vivo release of endogenous dopamine from rat caudate nucleus by phenylethylamine
Abstract
The in vivo release of endogenous dopamine (DA) from the rat caudate nucleus has been measured in the presence and absence of beta-phenylethylamine. A push-pull cannula was implanted into the brain and the tissue was perfused with artificial cerebrospinal fluid (CSF) containing phenylethylamine in concentrations ranging from 5 X 10(-3) to 5 X 10(-7) M. The DA released into the perfusate was determined radioenzymatically. Dopamine was released at rates significantly greater than its resting rate by concentrations of phenylethylamine of 5 X 10(-3) to 5 X 10(-5)M; 5 X 10(-6)M phenylethylamine caused a slight increase in release, but the difference from the resting rate was not significant. The absence of calcium in the perfusing medium did not significantly alter either the unstimulated release rate of DA or the release rate stimulated by 5 X 10(-5)M phenylethylamine. The concentrations of phenylethylamine required to increase release of DA in vivo are discussed briefly in relation to the doses required to elicit behavioural effects.
Similar articles
-
In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine.Neurochem Res. 1987 Feb;12(2):173-8. doi: 10.1007/BF00979534. Neurochem Res. 1987. PMID: 2437473
-
Amphetamine-stimulated release of endogenous dopamine from the rat caudate nucleus in vivo.Neurochem Res. 1983 Jun;8(6):731-41. doi: 10.1007/BF00964730. Neurochem Res. 1983. PMID: 6621771
-
In vivo release of endogenous dopamine from rat caudate putamen and nucleus accumbens by 40 mM potassium chloride.Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(4-6):817-20. doi: 10.1016/0278-5846(83)90074-x. Prog Neuropsychopharmacol Biol Psychiatry. 1983. PMID: 6686714
-
In vivo release of endogenous dopamine from rat caudate nucleus by beta-phenylethylamine and alpha,alpha,-dideutero-beta-phenylethylamine.Life Sci. 1986 Dec 22;39(25):2395-400. doi: 10.1016/0024-3205(86)90480-7. Life Sci. 1986. PMID: 3796200
-
In vivo release of endogenous dopamine from rat caudate nucleus induced by amphetamine and other agents.Ann N Y Acad Sci. 1986;473:200-12. doi: 10.1111/j.1749-6632.1986.tb23616.x. Ann N Y Acad Sci. 1986. PMID: 3467625 No abstract available.
Cited by
-
Behavioral sensitization to beta-phenylethylamine (PEA): enduring modifications of specific dopaminergic neuron systems in the rat.Psychopharmacology (Berl). 1990;102(1):5-10. doi: 10.1007/BF02245736. Psychopharmacology (Berl). 1990. PMID: 2392508
-
Decreased beta-phenylethylamine in CSF in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1997 Dec;63(6):754-8. doi: 10.1136/jnnp.63.6.754. J Neurol Neurosurg Psychiatry. 1997. PMID: 9416810 Free PMC article.
-
Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo.Br J Pharmacol. 1999 Feb;126(4):997-1002. doi: 10.1038/sj.bjp.0702389. Br J Pharmacol. 1999. PMID: 10193780 Free PMC article.
-
2-Phenylethylamine-induced changes in catecholamine receptor density: implications for antidepressant drug action.Neurochem Res. 1993 Sep;18(9):1015-22. doi: 10.1007/BF00966762. Neurochem Res. 1993. PMID: 7901780 Review.
-
Determination of regional distributions of phenylethylamine and meta- and para-tyramine in rat brain regions and presence in human and dog plasma by an ultra-sensitive negative chemical ion gas chromatography-mass spectrometric (NCI-GC-MS) method.Neurochem Res. 1993 Sep;18(9):995-1002. doi: 10.1007/BF00966759. Neurochem Res. 1993. PMID: 8232728
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources